Spineguard Stock

Spineguard PEG

The PEG Ratio (Price/Earnings-to-Growth) of Spineguard (ALSGD.PA) as of Aug 10, 2026 is -0.06. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -0.08 — a change of -16.39% (higher).

PEG

-0.06

YoY

-16.39%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Spineguard is 2026 -0.06 . PEG Ratio (Price/Earnings-to-Growth) of Spineguard was 2025 -0.08 . It decreases by -16.39% higher compared to the previous year.
Access this data via the Eulerpool API

Spineguard Stock analysis

What does Spineguard do? SpineGuard SA is a French company that operates in the field of medical technology. The company was founded in 2009 and is headquartered in Paris. SpineGuard is a leading provider of instruments and devices to improve the precision and effectiveness of spinal surgeries. The company focuses on developing and marketing products in the field of spinal surgery, enhancing surgical instruments and devices to assist and facilitate surgeons in performing spinal operations. SpineGuard succeeds by bringing innovative products to the market, partnering with leading orthopedic companies, and addressing customer needs. The company offers a wide range of instruments and devices for spinal surgeries, including a bone slurper, vertebral body tensioner, and pedicle shaver. It has also developed the DSG (Dynamic Surgical Guidance) technology, which provides real-time feedback to surgeons during operations, improving surgical precision and reducing the risk of complications. SpineGuard operates in three areas: instrument and device development for spinal surgery, partnerships with leading orthopedic companies, and sales and marketing. The company constantly strives to improve its products and introduce new developments to the market. In conclusion, SpineGuard is an innovative company that focuses on improving surgical instruments and devices in spinal surgery. It has established a strong presence in the medical technology market with its wide range of products and technologies. By partnering with leading orthopedic companies and utilizing a dedicated sales and marketing team, SpineGuard aims to make its products accessible to a broader audience. The company is customer-focused and continually seeks to bring innovative products to market to enhance surgical precision and effectiveness. Spineguard is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spineguard stock

PEG Ratio (Price/Earnings-to-Growth) of Spineguard is -0.06 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Spineguard changed from -0.08 to -0.06, representing a -16.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Spineguard since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Spineguard with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Spineguard

All Key Metrics — Spineguard